Weight Loss and Obesity Research
Participate in TRIPLE G, a study to understand the effect of an investigational drug compared to placebo (a drug that looks like the study drug but has no active medicine) on calorie intake, different uses of energy in the body and appetite.
About TRIPLE G
Our new clinical trial, called TRIPLE G, will study the effect of an investigational drug compared to placebo (a drug that looks like the study drug but has no active medicine) on calorie intake, different uses of energy in the body and appetite.
Participants may be compensated up to $15,000.
- Between 18 and 60 years of age
- BMI > 30.0 kg/m2
- Have not been diagnosed with Type 2 diabetes
- Stable weight (change of less than 5kg (11 pounds) over past 3 months
- Have not had any of the following treatments for obesity within 1 year prior, and have no plans to undergo any of these during the study period:
- Liposuction
- Cryolipolysis
- Abdominoplasty
- A history of at least 1 self-reported unsuccessful dietary effort to reduce body weight
- No prior or planned weight loss procedure, such as bariatric surgery, endoscopic therapy, or device-based therapy (unless removed at least 6-months prior)
- 1 Screening Visit
- Up to 15 Outpatient Visits
- Two 5-Day Inpatient Visits
- Two 3-day Inpatient Visits
- Vital signs, ECG, weight, height and BMI
- Blood draws and urine collections
- Physical examination and questionnaires
- Dietary counseling Body Composition Testing
- Activity Testing
- Test with Meal Testing
- Metabolic Testing
Qualified participants may be compensated up to $15,000 for their time and commitment.
If you're interested in learning more about the TRIPLE G study, please complete the form provided below, or you can reach out to our study team directly at (407)303-7193.
Let Us Help You
A Study Backed by the Translational Research Institute
The mission of the Translational Research Institute (TRI) is to extend and improve the quality of lives through the conduct of world-class, innovative translational research that leads to discoveries – and ultimately cures – for obesity, diabetes, and cardiovascular diseases.
Learn More